BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8967745)

  • 1. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
    Gurney ME; Cutting FB; Zhai P; Doble A; Taylor CP; Andrus PK; Hall ED
    Ann Neurol; 1996 Feb; 39(2):147-57. PubMed ID: 8967745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
    Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
    Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
    Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
    Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
    Chritin M; Savasta M; Besson G
    Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
    Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
    Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to therapy of amyotrophic lateral sclerosis.
    Miller RG
    West J Med; 1998 Apr; 168(4):262-3. PubMed ID: 9584665
    [No Abstract]   [Full Text] [Related]  

  • 8. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
    Nakano R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.
    Dupuis L; Mbebi C; Gonzalez de Aguilar JL; Rene F; Muller A; de Tapia M; Loeffler JP
    Mol Cell Neurosci; 2002 Feb; 19(2):216-24. PubMed ID: 11860274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
    Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of nuclear factor-kappaB activation increased glutamate excitotoxicity in a motoneuron-neuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn-superoxide dismutase.
    Pyo JS; Ko YS; Kim WH; Kim M; Lee KW; Nam SY; Chung HY; Cho SJ; Baik TK; Lee BL
    J Neurosci Res; 2010 Aug; 88(11):2494-503. PubMed ID: 20623531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies.
    Gurney ME
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S67-73. PubMed ID: 9419057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Liu R; Althaus JS; Ellerbrock BR; Becker DA; Gurney ME
    Ann Neurol; 1998 Nov; 44(5):763-70. PubMed ID: 9818932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic animal models of familial amyotrophic lateral sclerosis.
    Gurney ME
    J Neurol; 1997 May; 244 Suppl 2():S15-20. PubMed ID: 9178166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis.
    Welty DF; Schielke GP; Rothstein JD
    Ann Pharmacother; 1995 Nov; 29(11):1164-7. PubMed ID: 8573965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis.
    McAllum EJ; Lim NK; Hickey JL; Paterson BM; Donnelly PS; Li QX; Liddell JR; Barnham KJ; White AR; Crouch PJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):586-90. PubMed ID: 23952668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model.
    Waibel S; Reuter A; Malessa S; Blaugrund E; Ludolph AC
    J Neurol; 2004 Sep; 251(9):1080-4. PubMed ID: 15372249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant CuZn superoxide dismutase in motor neuron disease.
    Gurney ME; Liu R; Althaus JS; Hall ED; Becker DA
    J Inherit Metab Dis; 1998 Aug; 21(5):587-97. PubMed ID: 9728338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis.
    Gurney ME; Fleck TJ; Himes CS; Hall ED
    Neurology; 1998 Jan; 50(1):62-6. PubMed ID: 9443458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history and the effects of gabapentin in amyotrophic lateral sclerosis.
    Mazzini L; Mora G; Balzarini C; Brigatti M; Pirali I; Comazzi F; Pastore E
    J Neurol Sci; 1998 Oct; 160 Suppl 1():S57-63. PubMed ID: 9851651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.